STOCKS / Finance

Biotech Hits 11-Year High On Potential To Dethrone Oxycodone

From News - Investor\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
March 20, 2017 - 2:57pm
Nektar stock popped to an 11-year high Monday after unveiling strong data for a pain-relief pill that could be an alternative to oxycodone.


Continue reading this article »